Sales decline 1.45% to Rs 44.82 crore
Net profit of Kilitch Drugs (India) rose 0.84% to Rs 3.59 crore in the quarter ended March 2024 as against Rs 3.56 crore during the previous quarter ended March 2023. Sales declined 1.45% to Rs 44.82 crore in the quarter ended March 2024 as against Rs 45.48 crore during the previous quarter ended March 2023.For the full year,net profit rose 39.71% to Rs 14.60 crore in the year ended March 2024 as against Rs 10.45 crore during the previous year ended March 2023. Sales rose 10.58% to Rs 154.37 crore in the year ended March 2024 as against Rs 139.60 crore during the previous year ended March 2023.
ParticularsQuarter EndedYear EndedMar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.Sales44.8245.48 -1 154.37139.60 11 OPM %15.8013.65 -15.6412.58 - PBDT6.236.03 3 22.7015.56 46 PBT5.305.11 4 19.3512.01 61 NP3.593.56 1 14.6010.45 40
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
